BrightGene Bio (China) Price History

688166 Stock   30.92  1.21  4.07%   
Below is the normalized historical share price chart for BrightGene Bio Medical extending back to November 08, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of BrightGene Bio stands at 30.92, as last reported on the 28th of January, with the highest price reaching 31.17 and the lowest price hitting 29.99 during the day.
200 Day MA
30.7579
50 Day MA
31.0172
Beta
0.386
 
Covid
If you're considering investing in BrightGene Stock, it is important to understand the factors that can impact its price. At this point, BrightGene Bio is very steady. BrightGene Bio Medical secures Sharpe Ratio (or Efficiency) of 0.0268, which signifies that the company had a 0.0268 % return per unit of risk over the last 3 months. We have found twenty-three technical indicators for BrightGene Bio Medical, which you can use to evaluate the volatility of the firm. Please confirm BrightGene Bio's Risk Adjusted Performance of 0.0013, standard deviation of 3.49, and Mean Deviation of 2.35 to double-check if the risk estimate we provide is consistent with the expected return of 0.0935%.
  
The current year's Other Stockholder Equity is expected to grow to about 21.5 M, whereas Total Stockholder Equity is forecasted to decline to about 1.4 B. . BrightGene Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0268

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage Risk688166Huge Risk
Negative Returns

Estimated Market Risk

 3.48
  actual daily
31
69% of assets are more volatile

Expected Return

 0.09
  actual daily
1
99% of assets have higher returns

Risk-Adjusted Return

 0.03
  actual daily
2
98% of assets perform better
Based on monthly moving average BrightGene Bio is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BrightGene Bio by adding it to a well-diversified portfolio.
Price Book
5.553
Enterprise Value Ebitda
70.2095
Price Sales
10.522
Shares Float
259.2 M
Wall Street Target Price
44.21

BrightGene Bio Stock Price History Chart

There are several ways to analyze BrightGene Stock price data. The simplest method is using a basic BrightGene candlestick price chart, which shows BrightGene Bio price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceNovember 13, 202435.93
Lowest PriceJanuary 21, 202528.77

BrightGene Bio January 28, 2025 Stock Price Synopsis

Various analyses of BrightGene Bio's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell BrightGene Stock. It can be used to describe the percentage change in the price of BrightGene Bio from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of BrightGene Stock.
BrightGene Bio Price Daily Balance Of Power 1.03 
BrightGene Bio Price Action Indicator 0.95 
BrightGene Bio Price Rate Of Daily Change 1.04 
BrightGene Bio Accumulation Distribution 381,995 

BrightGene Bio January 28, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in BrightGene Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use BrightGene Bio intraday prices and daily technical indicators to check the level of noise trading in BrightGene Stock and then apply it to test your longer-term investment strategies against BrightGene.

BrightGene Stock Price History Data

The price series of BrightGene Bio for the period between Wed, Oct 30, 2024 and Tue, Jan 28, 2025 has a statistical range of 7.16 with a coefficient of variation of 5.38. The prices are distributed with arithmetic mean of 31.17. The median price for the last 90 days is 30.92. The company issued dividends on 2024-07-04.
OpenHighLowCloseVolume
01/27/2025 29.99  31.17  29.99  30.92  10,090,502 
01/24/2025 29.68  30.07  29.26  29.71  8,002,388 
01/23/2025 30.00  30.87  29.64  29.70  7,985,220 
01/22/2025 28.60  31.50  28.46  30.21  14,156,165 
01/21/2025 29.20  29.20  28.51  28.77  4,943,949 
01/20/2025 29.90  30.11  28.55  29.05  7,403,096 
01/17/2025 29.89  30.24  29.61  29.68  4,456,301 
01/16/2025 29.50  30.10  29.30  30.10  5,389,062 
01/15/2025 29.65  29.91  29.32  29.38  4,292,706 
01/14/2025 28.87  29.68  28.72  29.55  6,679,561 
01/13/2025 28.82  29.20  28.45  28.87  3,618,597 
01/10/2025 29.17  29.70  29.01  29.01  3,017,217 
01/09/2025 29.70  29.70  29.11  29.31  3,126,807 
01/08/2025 29.69  29.95  28.65  29.55  5,960,414 
01/07/2025 30.30  30.30  29.07  29.56  7,365,945 
01/06/2025 30.50  31.20  30.11  30.20  8,666,442 
01/03/2025 29.71  30.63  29.50  29.66  6,684,980 
01/02/2025 30.02  30.50  29.52  29.75  5,522,563 
12/31/2024 31.03  31.08  30.20  30.20  6,115,861 
12/30/2024 31.70  32.20  30.90  30.99  5,970,410 
12/27/2024 31.77  32.47  31.51  31.70  6,879,936 
12/26/2024 30.18  31.94  30.02  31.85  11,855,498 
12/25/2024 30.20  30.30  29.55  30.14  5,749,693 
12/24/2024 30.32  30.50  29.95  30.14  5,564,573 
12/23/2024 31.45  31.55  30.06  30.28  8,398,700 
12/20/2024 32.32  32.32  31.21  31.39  7,479,374 
12/19/2024 31.65  32.39  31.65  32.03  5,604,043 
12/18/2024 33.35  33.73  31.71  32.01  9,475,636 
12/17/2024 33.50  33.93  33.16  33.23  8,517,926 
12/16/2024 32.87  34.56  32.62  33.60  13,011,167 
12/13/2024 33.22  33.48  32.13  33.20  12,244,865 
12/12/2024 31.59  34.06  31.01  33.80  16,539,668 
12/11/2024 32.19  32.25  31.05  31.36  8,626,275 
12/10/2024 32.78  32.99  32.00  32.30  9,229,067 
12/09/2024 32.83  33.14  31.61  32.00  8,096,318 
12/06/2024 32.60  32.82  31.75  32.79  9,146,273 
12/05/2024 33.20  33.25  32.13  32.59  7,211,726 
12/04/2024 32.90  33.82  32.60  33.12  10,803,650 
12/03/2024 32.27  32.76  31.72  32.76  9,554,165 
12/02/2024 31.80  32.55  31.52  32.35  9,964,512 
11/29/2024 31.39  32.35  31.08  31.96  9,138,894 
11/28/2024 32.30  32.30  31.30  31.60  6,503,778 
11/27/2024 31.00  32.17  30.71  32.00  11,290,591 
11/26/2024 31.31  31.90  30.87  30.89  6,296,610 
11/25/2024 30.35  31.65  30.27  31.65  9,956,562 
11/22/2024 32.20  32.80  30.32  30.35  10,648,088 
11/21/2024 32.16  32.48  31.30  31.90  8,832,830 
11/20/2024 31.51  32.70  31.40  32.15  12,473,017 
11/19/2024 30.00  32.40  30.00  31.65  15,371,968 
11/18/2024 31.07  31.40  29.62  29.90  14,102,525 
11/15/2024 33.10  33.79  31.10  31.22  17,912,120 
11/14/2024 37.11  37.40  33.30  33.56  16,989,259 
11/13/2024 35.39  36.15  33.90  35.93  18,381,809 
11/12/2024 35.00  36.99  35.00  35.56  26,053,755 
11/11/2024 32.06  36.26  32.06  35.56  31,054,588 
11/08/2024 31.03  31.46  30.40  30.59  13,442,074 
11/07/2024 29.62  30.75  29.55  30.66  12,435,919 
11/06/2024 30.18  30.74  29.02  29.75  11,702,266 
11/05/2024 29.00  30.03  28.70  30.03  12,337,340 
11/04/2024 28.94  29.60  28.88  29.22  6,920,671 
11/01/2024 30.00  30.80  28.68  28.79  13,846,231 

About BrightGene Bio Stock history

BrightGene Bio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BrightGene is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BrightGene Bio Medical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BrightGene Bio stock prices may prove useful in developing a viable investing in BrightGene Bio
Last ReportedProjected for Next Year
Common Stock Shares Outstanding485.8 M340.7 M
Net Income Applicable To Common Shares275.6 M141.5 M

BrightGene Bio Quarterly Net Working Capital

497.03 Million

BrightGene Bio Stock Technical Analysis

BrightGene Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of BrightGene Bio technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of BrightGene Bio trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run ETFs Now

   

ETFs

Find actively traded Exchange Traded Funds (ETF) from around the world
All  Next Launch Module

BrightGene Bio Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for BrightGene Bio's price direction in advance. Along with the technical and fundamental analysis of BrightGene Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BrightGene to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for BrightGene Stock analysis

When running BrightGene Bio's price analysis, check to measure BrightGene Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BrightGene Bio is operating at the current time. Most of BrightGene Bio's value examination focuses on studying past and present price action to predict the probability of BrightGene Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BrightGene Bio's price. Additionally, you may evaluate how the addition of BrightGene Bio to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets